Financing channel feed – Endpoints News

Financing channel feed

Fast ex-Flexus team takes Arcus to a quick $100M IPO to advance I/O pipeline

8 years ago

Is NYC a biotech hub? Gut-brain startup Kallyope, equipped with $66M in new money, says yes

8 years ago

AI startup BioXcel Therapeutics shoots for $69M IPO with drugs for Alzheimer's, cancer

8 years ago

GV-backed startup Rani gets $53M from new investors for 'robotic pill'

8 years ago

North of a billion biotech VC dollars to come from C-Bridge, Rothschild as global biopharma capital flows

8 years ago

Taking on lousy side effects of existing meds, NEA-backed Xoc tackles Parkinson’s/migraines with $30M Series A

8 years ago

Hans Bishop gets a $287M payday as Juno execs see windfall fortunes — with a $922M payoff for Arch

8 years ago

Billion-dollar biosim maker mulls $500M Hong Kong IPO

8 years ago

Moderna boosts unicorn status with a whopping $500M raise and $7B valuation

8 years ago

With a potential cure for lysosomal storage disorders in hand, Avrobio raises $60M to back gene therapy pipeline

8 years ago

Startup with Johns Hopkins roots raising $40.5 million to develop cancer metabolism drugs

8 years ago

Corbus Pharma reels in $25M to pay for its PhIIb cystic fibrosis study, shares sink

8 years ago

In post-IPO party, Nasdaq’s newcomers Armo, Menlo and Solid soar within hours of listing

8 years ago

Duchenne MD dad pivots from last-minute alert on FDA's partial hold to $125M IPO for Solid Bio

8 years ago

Menlo bags $119M IPO on promise of ex-Merck drug

8 years ago

When VCs hand out mega-rounds to Vir and Gossamer, are they betting on the jockey or the horse?

8 years ago

What are the top 10 corporate VCs in biopharma today? And what do they want to fund — or steer clear of?

8 years ago

With $58M in hand, the startup team at Pandion sets their sights on a next-gen approach to immunology

8 years ago

Where the money is: Top 100 VCs investing in US biotechs during 2017

8 years ago

China biotech unicorn Innovent in talks on $200M IPO and new funding — report

8 years ago

German drugmaker files $21.6M IPO for skin cancer drug

8 years ago

Google backs $27M launch round for Holy Grail R&D work on two targets: a cancer vaccine and a universal flu jab

8 years ago

Truffle roots for new biotechs after first close of a planned $240M fund

8 years ago

Boasting a late-stage Botox me-too, Evolus files for $75M IPO

8 years ago

First page Previous page 133 134 135136137 138 139 Next page Last page